mesalamine has been researched along with Headache in 10 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of this study is to evaluate the safety and efficacy of Small intestinal release mesalamine (SIRM) for symptom relief in refractory celiac disease (RCD)." | 7.77 | Small intestinal release mesalamine for the treatment of refractory celiac disease type I. ( Dennis, M; Jamma, S; Kelly, CP; Leffler, DA; Najarian, RM; Schuppan, DB; Sheth, S, 2011) |
| " We report a 22 year-old male with ulcerative colitis in treatment with mesalazine and prednisone presenting with headache and speech disturbances." | 3.81 | [Intracranial sinus venous thrombosis in ulcerative colitis. Report of one case]. ( Bagattini, JC; Calcagno, GP; Chiarella, M; Cohen, H; Forster, TA, 2015) |
| "The goal of this study is to evaluate the safety and efficacy of Small intestinal release mesalamine (SIRM) for symptom relief in refractory celiac disease (RCD)." | 3.77 | Small intestinal release mesalamine for the treatment of refractory celiac disease type I. ( Dennis, M; Jamma, S; Kelly, CP; Leffler, DA; Najarian, RM; Schuppan, DB; Sheth, S, 2011) |
| "A randomized, 2-way, crossover study was conducted in 30 volunteers to compare the pharmacokinetic profile of a new once-daily dosing regimen of mesalazine (1 x 4 g/d) with the current twice-daily dosage (2 x 2 g/d) used in many European countries." | 2.73 | Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers. ( Gandia, P; Houin, G; Idier, I, 2007) |
| "To report a case of benign intracranial hypertension related to mesalazine use." | 1.32 | Mesalazine-associated benign intracranial hypertension in a patient with ulcerative colitis. ( Giamundo, A; Iaccarino, G; Jura, A; Romano, A; Rosa, N, 2003) |
| "Use of sulphasalazine in ulcerative colitis patients is hampered by a variety of side-effects, including male infertility." | 1.31 | Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects. ( Crispino, P; Di Paolo, MC; Iacopini, F; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M; Spera, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calcagno, GP | 1 |
| Bagattini, JC | 1 |
| Forster, TA | 1 |
| Chiarella, M | 1 |
| Cohen, H | 1 |
| Lawlor, G | 1 |
| Ahmed, A | 1 |
| Moss, AC | 1 |
| Jamma, S | 1 |
| Leffler, DA | 1 |
| Dennis, M | 1 |
| Najarian, RM | 1 |
| Schuppan, DB | 1 |
| Sheth, S | 1 |
| Kelly, CP | 1 |
| Rosa, N | 1 |
| Giamundo, A | 1 |
| Jura, A | 1 |
| Iaccarino, G | 1 |
| Romano, A | 1 |
| Gandia, P | 1 |
| Idier, I | 1 |
| Houin, G | 1 |
| Martín Rodríguez, MM | 1 |
| Ruiz-Cabello Jiménez, M | 1 |
| Gómez García, M | 1 |
| Vega Villaamil, P | 1 |
| González Castillo, S | 1 |
| Green, JR | 1 |
| Gibson, JA | 1 |
| Kerr, GD | 1 |
| Swarbrick, ET | 1 |
| Lobo, AJ | 1 |
| Holdsworth, CD | 1 |
| Crowe, JP | 1 |
| Schofield, KJ | 1 |
| Taylor, MD | 1 |
| Rottembourg, D | 1 |
| Labarthe, F | 1 |
| Arsene, S | 1 |
| Jonville-Béra, AP | 1 |
| Maurage, C | 1 |
| Rolland, JC | 1 |
| Di Paolo, MC | 1 |
| Paoluzi, OA | 1 |
| Pica, R | 1 |
| Iacopini, F | 1 |
| Crispino, P | 1 |
| Rivera, M | 1 |
| Spera, G | 1 |
| Paoluzi, P | 1 |
| Daneshmend, TK | 1 |
2 trials available for mesalamine and Headache
| Article | Year |
|---|---|
Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers.
Topics: Acetylglucosaminidase; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroi | 2007 |
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Anti-Ulcer Agents; Colitis, Ulcerative; Delayed-Actio | 1998 |
8 other studies available for mesalamine and Headache
| Article | Year |
|---|---|
[Intracranial sinus venous thrombosis in ulcerative colitis. Report of one case].
Topics: Anti-Inflammatory Agents; Anticoagulants; Cerebral Infarction; Colitis, Ulcerative; Enoxaparin; Head | 2015 |
Once-daily mesalamine granules for ulcerative colitis.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Colitis, Ulcerati | 2010 |
Small intestinal release mesalamine for the treatment of refractory celiac disease type I.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Celiac Disease; | 2011 |
Mesalazine-associated benign intracranial hypertension in a patient with ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Headache; Humans; Mesal | 2003 |
[Benign intracranial hypertension and ulcerative colitis].
Topics: Acetazolamide; Adult; Anti-Inflammatory Agents, Non-Steroidal; Carbonic Anhydrase Inhibitors; Coliti | 2007 |
Headache during mesalamine therapy: a case report of mesalamine-induced pseudotumor cerebri.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Female; Headache; Humans; Mesalamine; Pseudotumor Ce | 2001 |
Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Desensitization, Im | 2001 |
Mesalazine-associated thrombocytopenia.
Topics: Aminosalicylic Acids; Female; Headache; Humans; Kidney Diseases; Mesalamine; Middle Aged; Thrombocyt | 1991 |